English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK
Sep 23, 2022 17:06 HKT
Malaysian Genomics Grows Presence in Thailand
Sep 23, 2022 14:00 HKT
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
Sep 22, 2022 14:13 HKT
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
Sep 21, 2022 19:00 HKT
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
Sep 20, 2022 23:50 HKT
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference
Sep 15, 2022 17:00 HKT
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
Sep 09, 2022 21:54 HKT
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
Sep 09, 2022 17:00 HKT
EC Healthcare Chairman Mr. Eddy Tang Further Increases Shareholding, Exhibiting Unwavering Assurance in the Future Development of the Group
Sep 09, 2022 16:46 HKT
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh
Sep 08, 2022 23:00 HKT
Dammam Valley and Arcensus GmbH announce establishment of the Saudi-German Genomic Center in Riyadh
Sep 08, 2022 20:00 HKT
EC Healthcare and AXA Jointly Establish the FIRST AXA Medical Centre
Sep 08, 2022 17:20 HKT
Sirnaomics to Present at 3rd Annual Jefferies Asia Forum
Sep 06, 2022 18:51 HKT
Oculis announces publication of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema
Sep 06, 2022 18:22 HKT
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
Sep 06, 2022 13:00 HKT
Dammam Valley to acquire majority in Arcensus GmbH; accelerating Whole Genome Sequencing in genetic diagnostics, delivering breakthrough technologies in genomic bioinformatics
Sep 05, 2022 20:00 HKT
Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC
Sep 05, 2022 18:00 HKT
EC Healthcare Chairman Mr. Eddy Tang Increases Shareholding, Demonstrating Full Confidence in the Group's Future Development
Sep 02, 2022 17:31 HKT
Legend Capital: The Logic of Technology Investment Has Changed
Sep 02, 2022 17:05 HKT
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market
Sep 02, 2022 14:33 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: